New York-based strategic communications and advisory firm ICR has picked up boutique healthcare PR firm Continuum Health Communications to expand its healthcare practice.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS